Drug Information
Drug General Information | Top | |||
---|---|---|---|---|
Drug ID |
D0F9YV
|
|||
Former ID |
DIB019620
|
|||
Drug Name |
PMID3514912C9
|
|||
Synonyms |
GTPL8559; BDBM50405350; ZINC27564601
Click to Show/Hide
|
|||
Drug Type |
Small molecular drug
|
|||
Indication | Discovery agent [ICD-11: N.A.] | Investigative | [1] | |
Structure |
Download2D MOL
|
|||
Formula |
C15H15N3O2
|
|||
Canonical SMILES |
CC1=CC=C(C=C1)OC(=O)C2=CC=C(C=C2)N=C(N)N
|
|||
InChI |
1S/C15H15N3O2/c1-10-2-8-13(9-3-10)20-14(19)11-4-6-12(7-5-11)18-15(16)17/h2-9H,1H3,(H4,16,17,18)
|
|||
InChIKey |
OELAPCOUDOSGBC-UHFFFAOYSA-N
|
|||
PubChem Compound ID | ||||
PubChem Substance ID |
Target and Pathway | Top | |||
---|---|---|---|---|
Target(s) | Acrosin (ACR) | Target Info | Inhibitor | [1] |
Cationic trypsinogen (PRSS1) | Target Info | Inhibitor | [1] | |
KEGG Pathway | Neuroactive ligand-receptor interaction | |||
Pancreatic secretion | ||||
Protein digestion and absorption | ||||
Influenza A | ||||
Reactome | Activation of Matrix Metalloproteinases | |||
Cobalamin (Cbl, vitamin B12) transport and metabolism | ||||
WikiPathways | Activation of Matrix Metalloproteinases |
References | Top | |||
---|---|---|---|---|
REF 1 | Synthesis and inhibition of human acrosin and trypsin and acute toxicity of aryl 4-guanidinobenzoates. J Med Chem. 1986 Apr;29(4):514-9. |
If You Find Any Error in Data or Bug in Web Service, Please Kindly Report It to Dr. Zhou and Dr. Zhang.